Braemar (LON:BMS – Get Free Report) had its price objective cut by equities research analysts at Canaccord Genuity Group from GBX 380 ($4.91) to GBX 350 ($4.52) in a research note issued on Monday,London Stock Exchange reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 40.56% from the company’s current price.
Braemar Stock Performance
Shares of LON:BMS traded down GBX 11 ($0.14) on Monday, reaching GBX 249 ($3.22). 141,316 shares of the company’s stock were exchanged, compared to its average volume of 61,081. The business’s 50-day moving average is GBX 257.58 and its two-hundred day moving average is GBX 261.65. The company has a quick ratio of 1.23, a current ratio of 1.42 and a debt-to-equity ratio of 43.61. Braemar has a fifty-two week low of GBX 221.01 ($2.85) and a fifty-two week high of GBX 317.64 ($4.10). The firm has a market capitalization of £80.35 million, a price-to-earnings ratio of 16.18 and a beta of 1.17.
Braemar Company Profile
Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers’ needs, and provide an integrated service supported by a collaborative culture.
Featured Articles
- Five stocks we like better than Braemar
- Low PE Growth Stocks: Unlocking Investment Opportunities
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
- NYSE Stocks Give Investors a Variety of Quality Options
- Taiwan Semiconductor Attracts Big Money on NVIDIA Chip Growth
- How to Buy Cheap Stocks Step by Step
- Is Meta’s Pushback on NVIDIA With In-House Chips Good for Shares?
Receive News & Ratings for Braemar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braemar and related companies with MarketBeat.com's FREE daily email newsletter.